Indraprastha Medical Corporation Ltd

Indrapr.Medical Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indraprastha Medical Corporation Ltd

₹ 488 -0.51%
11 Jul - close price
delhi.apollohospitals.com BSE: 532150 NSE: INDRAMEDCO
About

Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]

Key Points

JV of Apollo
IMCL is a JV between Apollo Hospital (22%) and the State Government of Delhi (26%), and has presence in the NCR with two facilities, a 718-bedded facility in Sarita Vihar (operational since 1996) and a 46-bedded facility in Noida (since 2006). [1]

Website BSE NSE
  • Market Cap ₹ 4,470 Cr.
  • Current Price ₹ 488
  • High / Low ₹ 572 / 232
  • Stock P/E 27.8
  • Book Value ₹ 65.1
  • Dividend Yield 0.92 %
  • ROCE 39.0 %
  • ROE 30.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 29.4% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.3%
  • Company has been maintaining a healthy dividend payout of 30.3%

Cons

  • Stock is trading at 7.49 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
216 263 284 277 274 307 317 306 315 348 350 325 334
188 226 241 240 241 259 267 259 266 281 286 273 272
Operating Profit 28 37 44 37 33 47 50 47 48 67 64 52 61
OPM % 13% 14% 15% 13% 12% 15% 16% 15% 15% 19% 18% 16% 18%
2 1 1 3 5 4 4 4 5 5 6 5 6
Interest 1 1 1 1 1 1 1 1 2 2 2 2 1
Depreciation 9 10 10 10 10 10 10 10 10 11 11 11 11
Profit before tax 20 27 34 29 27 40 44 41 42 60 57 45 55
Tax % 24% 24% 26% 29% 27% 24% 25% 28% 25% 25% 26% 26% 26%
15 20 25 21 20 30 33 29 31 45 42 33 41
EPS in Rs 1.66 2.21 2.74 2.28 2.16 3.33 3.58 3.21 3.40 4.88 4.63 3.58 4.47
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
678 714 755 766 753 788 831 613 888 1,099 1,245 1,356
587 630 675 686 678 706 743 572 768 947 1,050 1,112
Operating Profit 91 85 80 79 74 82 87 41 120 152 195 244
OPM % 13% 12% 11% 10% 10% 10% 11% 7% 14% 14% 16% 18%
1 1 1 -0 -1 -1 -0 -0 -3 9 16 23
Interest 10 8 7 8 9 7 6 3 3 4 4 6
Depreciation 28 28 35 31 31 30 33 33 35 39 40 44
Profit before tax 54 50 39 41 34 45 48 4 79 117 166 216
Tax % 35% 34% 37% 36% 38% 36% 9% 46% 26% 26% 25% 26%
35 32 24 26 21 28 44 2 59 86 124 161
EPS in Rs 3.87 3.54 2.66 2.86 2.30 3.10 4.76 0.25 6.39 9.40 13.52 17.56
Dividend Payout % 47% 51% 68% 63% 65% 52% 0% 0% 39% 32% 33% 26%
Compounded Sales Growth
10 Years: 7%
5 Years: 10%
3 Years: 15%
TTM: 9%
Compounded Profit Growth
10 Years: 17%
5 Years: 29%
3 Years: 37%
TTM: 29%
Stock Price CAGR
10 Years: 22%
5 Years: 58%
3 Years: 105%
1 Year: 100%
Return on Equity
10 Years: 19%
5 Years: 23%
3 Years: 28%
Last Year: 30%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 92 92 92 92 92 92 92 92 92 92 92 92
Reserves 95 103 132 139 141 152 176 181 234 288 386 505
63 50 52 67 66 21 4 3 5 2 34 33
199 196 185 160 134 157 177 157 131 173 212 222
Total Liabilities 449 442 460 458 432 422 449 432 462 555 723 852
293 286 301 296 294 280 303 283 277 275 347 328
CWIP 2 3 3 0 0 1 0 3 0 3 0 33
Investments 0 0 0 0 0 0 0 0 0 0 0 0
154 153 157 163 138 141 146 145 185 278 376 491
Total Assets 449 442 460 458 432 422 449 432 462 555 723 852

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
58 64 62 28 48 75 86 27 94 144 200 157
-22 -29 -33 -22 -30 -17 -40 -19 -74 -108 -158 -111
-36 -35 -30 -5 -17 -44 -43 -3 -3 -26 -32 -46
Net Cash Flow 0 -0 -0 -0 1 14 4 5 17 11 9 -0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 35 40 41 47 41 35 35 40 18 23 17 20
Inventory Days 11
Days Payable 194
Cash Conversion Cycle 35 40 41 47 41 35 35 40 18 23 17 -163
Working Capital Days -19 -23 0 14 12 -5 -8 0 -1 -11 -24 -18
ROCE % 26% 23% 18% 17% 15% 19% 21% 3% 29% 34% 38% 39%

Shareholding Pattern

Numbers in percentages

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00% 51.00%
0.09% 0.15% 0.77% 0.27% 0.37% 0.81% 0.95% 1.08% 1.70% 2.64% 2.88% 2.94%
0.02% 0.02% 0.00% 0.00% 0.00% 6.71% 6.36% 4.91% 3.14% 3.19% 3.18% 3.56%
48.89% 48.83% 48.22% 48.72% 48.62% 41.49% 41.69% 43.01% 44.14% 43.16% 42.91% 42.50%
No. of Shareholders 55,29055,28752,76049,83348,63047,86551,44854,15855,10364,67169,69770,491

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings